ARO-ANG 3 Injection
AROANG3-2003
Phase 2 small_molecule terminated
Quick answer
ARO-ANG 3 Injection for Homozygous Familial Hypercholesterolemia is a Phase 2 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARROWHEAD PHARMACEUTICALS, INC.
- Indication
- Homozygous Familial Hypercholesterolemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated